Article Versions Notes

Ali MS, Magnati S, Panuzzo C, Cilloni D, Saglio G, Pergolizzi B, Bracco E. The Downregulation of Both Giant HERCs, HERC1 and HERC2, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation. Journal of Clinical Medicine. 2022; 11(2):324. https://doi.org/10.3390/jcm11020324

Ali, Muhammad Shahzad, Stefano Magnati, Cristina Panuzzo, Daniela Cilloni, Giuseppe Saglio, Barbara Pergolizzi, and Enrico Bracco. 2022. "The Downregulation of Both Giant HERCs, HERC1 and HERC2, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation" Journal of Clinical Medicine 11, no. 2: 324. https://doi.org/10.3390/jcm11020324

Ali, M. S., Magnati, S., Panuzzo, C., Cilloni, D., Saglio, G., Pergolizzi, B., & Bracco, E. (2022). The Downregulation of Both Giant HERCs, HERC1 and HERC2, Is an Unambiguous Feature of Chronic Myeloid Leukemia, and HERC1 Levels Are Associated with Leukemic Cell Differentiation. Journal of Clinical Medicine, 11(2), 324. https://doi.org/10.3390/jcm11020324